The ATR inhibitor ceralasertib potentiates cancer checkpoint immunotherapy by regulating the tumor microenvironment
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
The ATR inhibitor ceralasertib potentiates cancer checkpoint immunotherapy by regulating the tumor microenvironment ; volume:15 ; number:1 ; day:24 ; month:2 ; year:2024 ; pages:1-20 ; date:12.2024
Nature Communications ; 15, Heft 1 (24.2.2024), 1-20, 12.2024
- Urheber
-
Hardaker, Elizabeth L.
Sanseviero, Emilio
Karmokar, Ankur
Taylor, Devon
Milo, Marta
Michaloglou, Chrysis
Hughes, Adina
Mai, Mimi
King, Matthew
Solanki, Anisha
Magiera, Lukasz
Miragaia, Ricardo
Kar, Gozde
Standifer, Nathan
Surace, Michael
Gill, Shaan
Peter, Alison
Talbot, Sara
Tohumeken, Sehmus
Fryer, Henderson
Mostafa, Ali
Mulgrew, Kathy
Lam, Carolyn
Hoffmann, Scott
Sutton, Daniel
Carnevalli, Larissa
Calero-Nieto, Fernando J.
Jones, Gemma N.
Pierce, Andrew J.
Wilson, Zena
Campbell, David
Nyoni, Lynet
Martins, Carla P.
Baker, Tamara
Serrano de Almeida, Gilberto
Ramlaoui, Zainab
Bidar, Abdel
Phillips, Benjamin
Boland, Joseph
Iyer, Sonia
Barrett, J. Carl
Loembé, Arsene-Bienvenu
Fuchs, Serge Y.
Duvvuri, Umamaheswar
Lou, Pei-Jen
Nance, Melonie A.
Gomez Roca, Carlos Alberto
Cadogan, Elaine
Critichlow, Susan E.
Fawell, Steven
Cobbold, Mark
Dean, Emma
Valge-Archer, Viia
Lau, Alan
Gabrilovich, Dmitry I.
Barry, Simon T.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41467-024-45996-4
- URN
-
urn:nbn:de:101:1-2405020846161.759567927400
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:49 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Hardaker, Elizabeth L.
- Sanseviero, Emilio
- Karmokar, Ankur
- Taylor, Devon
- Milo, Marta
- Michaloglou, Chrysis
- Hughes, Adina
- Mai, Mimi
- King, Matthew
- Solanki, Anisha
- Magiera, Lukasz
- Miragaia, Ricardo
- Kar, Gozde
- Standifer, Nathan
- Surace, Michael
- Gill, Shaan
- Peter, Alison
- Talbot, Sara
- Tohumeken, Sehmus
- Fryer, Henderson
- Mostafa, Ali
- Mulgrew, Kathy
- Lam, Carolyn
- Hoffmann, Scott
- Sutton, Daniel
- Carnevalli, Larissa
- Calero-Nieto, Fernando J.
- Jones, Gemma N.
- Pierce, Andrew J.
- Wilson, Zena
- Campbell, David
- Nyoni, Lynet
- Martins, Carla P.
- Baker, Tamara
- Serrano de Almeida, Gilberto
- Ramlaoui, Zainab
- Bidar, Abdel
- Phillips, Benjamin
- Boland, Joseph
- Iyer, Sonia
- Barrett, J. Carl
- Loembé, Arsene-Bienvenu
- Fuchs, Serge Y.
- Duvvuri, Umamaheswar
- Lou, Pei-Jen
- Nance, Melonie A.
- Gomez Roca, Carlos Alberto
- Cadogan, Elaine
- Critichlow, Susan E.
- Fawell, Steven
- Cobbold, Mark
- Dean, Emma
- Valge-Archer, Viia
- Lau, Alan
- Gabrilovich, Dmitry I.
- Barry, Simon T.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Tumor microenvironment reprogramming combined with immunogenic enhancement by nanoemulsions potentiates immunotherapy
Sculpting the tumour microenvironment by combining radiotherapy and ATR inhibition for curative-intent adjuvant immunotherapy
Local Exosome Inhibition Potentiates Mild Photothermal Immunotherapy Against Breast Cancer
Cancer immunotherapy beyond immune checkpoint inhibitors
Remodelling of tumour microenvironment by microwave ablation potentiates immunotherapy of AXL-specific CAR T cells against non-small cell lung cancer
ATR
Targeting CDC7 potentiates ATR-CHK1 signaling inhibition through induction of DNA replication stress in liver cancer
Endothelin Inhibition Potentiates Cancer Immunotherapy Revealing Mechanical Biomarkers Predictive of Response
Tumor microenvironment and immunotherapy of oral cancer
Immune checkpoint inhibitors for multiple myeloma immunotherapy
Aptamer targeted therapy potentiates immune checkpoint blockade in triple-negative breast cancer
Radiation combined with macrophage depletion promotes adaptive immunity and potentiates checkpoint blockade
Tumor microenvironment reprogramming combined with immunogenic enhancement by nanoemulsions potentiates immunotherapy
Sculpting the tumour microenvironment by combining radiotherapy and ATR inhibition for curative-intent adjuvant immunotherapy
Local Exosome Inhibition Potentiates Mild Photothermal Immunotherapy Against Breast Cancer
Cancer immunotherapy beyond immune checkpoint inhibitors
Remodelling of tumour microenvironment by microwave ablation potentiates immunotherapy of AXL-specific CAR T cells against non-small cell lung cancer
ATR
Targeting CDC7 potentiates ATR-CHK1 signaling inhibition through induction of DNA replication stress in liver cancer
Endothelin Inhibition Potentiates Cancer Immunotherapy Revealing Mechanical Biomarkers Predictive of Response
Tumor microenvironment and immunotherapy of oral cancer
Immune checkpoint inhibitors for multiple myeloma immunotherapy
Aptamer targeted therapy potentiates immune checkpoint blockade in triple-negative breast cancer
Radiation combined with macrophage depletion promotes adaptive immunity and potentiates checkpoint blockade
Tumor microenvironment reprogramming combined with immunogenic enhancement by nanoemulsions potentiates immunotherapy
Sculpting the tumour microenvironment by combining radiotherapy and ATR inhibition for curative-intent adjuvant immunotherapy
Local Exosome Inhibition Potentiates Mild Photothermal Immunotherapy Against Breast Cancer
Cancer immunotherapy beyond immune checkpoint inhibitors
Remodelling of tumour microenvironment by microwave ablation potentiates immunotherapy of AXL-specific CAR T cells against non-small cell lung cancer
ATR
Targeting CDC7 potentiates ATR-CHK1 signaling inhibition through induction of DNA replication stress in liver cancer
Endothelin Inhibition Potentiates Cancer Immunotherapy Revealing Mechanical Biomarkers Predictive of Response
Tumor microenvironment and immunotherapy of oral cancer
Immune checkpoint inhibitors for multiple myeloma immunotherapy
Aptamer targeted therapy potentiates immune checkpoint blockade in triple-negative breast cancer